Ajinkya M Pawar (Ajinkya Pawar)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 5

Top Venues

Thrombosis and haemostasis

JMIR public health and surveillance

Annals of the rheumatic diseases

Clinical pharmacology and therapeutics

Brigham and Women's Hospital

University of Rhode Island (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Brigham and Women's Hospital Dec 16 2016

United States

Research Specialist :: Pharmacoepidemiology and Pharmacoeconomics

Education History

University of Rhode Island Jan 12 2012 - Dec 30 2016

United States

PHD :: Pharmacy Practice

Publications

Kueiyu Joshua Lin, Sebastian Schneeweiss, Ajinkya M Pawar, Daniel E Singer, Jun Liu, Joshua J Gagne
Using a Simple Prescription Gap to Determine Warfarin Discontinuation Can Lead to Substantial Misclassification. Thrombosis and haemostasis (2021)
Ajinkya M Pawar, Rishi J Desai, Mengdong He, Lily Bessette, Seoyoung C Kim
Comparative Risk of Nonvertebral Fractures Among Patients With Rheumatoid Arthritis Treated With Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drugs. ACR open rheumatology 3 (8) (2021)
Jessica M Franklin, Ajinkya M Pawar, David Martin, Robert J Glynn, Mark Levenson, Robert Temple, Sebastian G Schneeweiss
Nonrandomized Real-World Evidence to Support Regulatory Decision Making: Process for a Randomized Trial Replication Project. Clinical pharmacology and therapeutics 107 (4) (2019)
Ajinkya M Pawar, Rishi J Desai, Daniel H Solomon, Adrian J Santiago Ortiz, Sara Gale, Min Bao, Khaled Sarsour, Sebastian Schneeweiss, Seoyoung C Kim
Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study. Annals of the rheumatic diseases 78 (4) (2019)
Michael S Sinha, Clark C Freifeld, John S Brownstein, Macarius M Donneyong, Paula Rausch, Brian M Lappin, Esther H Zhou, Gerald J Dal Pan, Ajinkya M Pawar, Thomas J Hwang, Jerry Avorn, Aaron S Kesselheim
Social Media Impact of the Food and Drug Administration's Drug Safety Communication Messaging About Zolpidem: Mixed-Methods Analysis. JMIR public health and surveillance 4 (1) (2018)

Ajinkya M Pawar.css-eqlu8i{font-size:small;padding-left:4px;} (Ajinkya Pawar)

Publication Activity (10 Years)

Top Topics

Top Venues

Ajinkya M Pawar (Ajinkya Pawar)